Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Epilepsy
Interventions
DRUG

"Lamotrigine Generic A"

DRUG

"Lamotrigine generic B"

Trial Locations (8)

14642

Michel J. Berg, MD, Rochester

19104

University of Pennsylvania, Philadelphia

35294

University of Alabama at Birmingham, Birmingham

45267

Michael Privitera, MD, Cincinnati

53705

University of Wisconsin-Madison, Madison

66160

University of Kansas, Kansas City

50311-4505

Drake University, Des Moines

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Epilepsy Foundation

OTHER

collaborator

American Epilepsy Society

OTHER

lead

University of Cincinnati

OTHER

NCT01713777 - Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design | Biotech Hunter | Biotech Hunter